Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Regenerative Medical Technology (RMTG) Short term Debt (2017 - 2025)

Historic Short term Debt for Regenerative Medical Technology (RMTG) over the last 8 years, with Q3 2025 value amounting to $7029.0.

  • Regenerative Medical Technology's Short term Debt changed N/A to $7029.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $7029.0, marking a year-over-year change of. This contributed to the annual value of $4689.0 for FY2024, which is 11849.95% up from last year.
  • Per Regenerative Medical Technology's latest filing, its Short term Debt stood at $7029.0 for Q3 2025.
  • Regenerative Medical Technology's 5-year Short term Debt high stood at $1.5 million for Q3 2021, and its period low was $2146.0 during Q4 2023.
  • For the 4-year period, Regenerative Medical Technology's Short term Debt averaged around $386178.5, with its median value being $6597.5 (2025).
  • Per our database at Business Quant, Regenerative Medical Technology's Short term Debt tumbled by 8996.49% in 2021 and then surged by 11849.95% in 2024.
  • Quarter analysis of 4 years shows Regenerative Medical Technology's Short term Debt stood at $1.5 million in 2021, then tumbled by 99.86% to $2146.0 in 2023, then soared by 118.5% to $4689.0 in 2024, then surged by 49.9% to $7029.0 in 2025.
  • Its Short term Debt was $7029.0 in Q3 2025, compared to $6166.0 in Q2 2025 and $5838.0 in Q1 2025.